The stock price of Veru Inc. , a biopharmaceuticals company focused on oncology medicines, has seen a monstrous 112% rise over the last ten trading days, while it's up 47% over the last five trading days, after the company reported positive phase 2 clinical trial results for VERU-111...
The stock price of Veru Inc. , a biopharmaceuticals company focused on oncology medicines, has seen a monstrous 112% rise over the last ten trading days, while it's up 47% over the last five trading days, after the company reported positive phase 2 clinical trial results for VERU-111...
Share this Article
Recommended